Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy

Zaid Bilgrami; Ameer Abutaleb; Kenechukwu Chudy-Onwugaje; Patricia Langenberg; Miguel Regueiro; David A Schwartz; J Kathleen Tracy; Leyla Ghazi; Seema A Patil; Sandra M Quezada; Katharine M Russman; Charlene C Quinn; Guruprasad Jambaulikar; Dawn B Beaulieu; Sara Horst; Raymond K Cross Jr

doi:10.1007/s10620-019-05953-4

Correction to: Effect of TELEmedicine for Inflammatory Bowel Disease on Patient Activation and Self-Efficacy

Dig Dis Sci. 2020 Feb;65(2):668. doi: 10.1007/s10620-019-05953-4.

Authors

Zaid Bilgrami¹, Ameer Abutaleb¹, Kenechukwu Chudy-Onwugaje¹, Patricia Langenberg¹, Miguel Regueiro², David A Schwartz³, J Kathleen Tracy¹, Leyla Ghazi⁴, Seema A Patil¹, Sandra M Quezada¹, Katharine M Russman¹, Charlene C Quinn¹, Guruprasad Jambaulikar⁵, Dawn B Beaulieu³, Sara Horst³, Raymond K Cross Jr⁶

Affiliations

¹ University of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA.
² University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
³ Vanderbilt University School of Medicine, Nashville, TN, USA.
⁴ Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA.
⁵ Brigham and Women's Hospital, Boston, MA, USA.
⁶ University of Maryland School of Medicine, 685 West Baltimore Street, Suite 8-00, Baltimore, MD, 21201, USA. rcross@som.umaryland.edu.

PMID: 31792670
DOI: 10.1007/s10620-019-05953-4

Abstract

This manuscript is a secondary analysis of a large multicenter randomized controlled trial. The primary study is Cross RK et al., A Randomized Controlled Trial of TELEmedicine for patients with Inflammatory Bowel Disease (TELE-IBD). Am J Gastroenterol, 2019 Mar.

Publication types

Published Erratum